HearingCompleted

Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.

Jul 15, 20262:15 PM2123, Rayburn House Office Building

Witnesses · 5

1

Dr. Cynthia Verst

President, Design and Delivery Innovation, R&D Solutions, IQVIA

2

Ms. Susan Winckler

CEO, Reagan-Udall Foundation for the FDA

3

Dr. Aaron Kowalski

CEO, Breakthrough T1D

4

Dr. Thomas Hwang

Assistant Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School

5

Mr. Thomas Bollyky

Bloomberg Chair in Global Health, Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council